Baxter International is selling its biopharma solutions business to private equity firms. The transaction is part of a broader trend in which life science firms are spinning out or selling operations in order to hone the focus of the remaining business on certain areas.
In a move that could position Walgreens to own one of the largest drug distributors to retail pharmacies and physicians, the retail drugstore giant is in talks with Amerisource Bergen, according to The Wall Street Journal.
Closing cancer health equity gaps require medical breakthroughs made possible by new funding approaches.
Baxter International, a medical device company, and Matter, a health technology incubator, will work together to improve healthcare quality and value.
The original agreement between Walgreens and Rite Aid is no more. Rather, Walgreens will pay $5.175 billion to purchase 2,186 Rite Aid stores.
Walgreens alleges that Theranos misled the retailer about the state of its technology when the two companies inked a deal, the article noted. The lawsuit follows another complaint against the blood testing business filed by Partner Fund Management.
Akari Therapeutics just got a big boost with additional proceeds due to private placement.
The future looks bright for the integrated specialty pharmacy model – for health systems, providers, and most importantly, for patients.